PathAI and AISight have collaborated to launch AIM-MASH on the AISight Image Management System, providing AI-based support for analyzing MASLD Activity Score component grades and fibrosis staging. With projections of 27 million MASH cases in the US by 2030, this tool aims to increase reproducibility and scalability for pathologists. Through over 20 presentations and publications, AIM-MASH has shown to offer highly sensitive and specific reviews, repeatable assessments, and increased scoring confidence, ultimately improving patient outcomes in pathology.